CBS and ovarian cancer: In addition to autocrine regulation, CBS acts via a paracrine mechanism to modulate the tumor microenvironment including stimulating angiogenesis and vasodilation via H2S production and release as reported in colon and ovarian cancer xenografts [8, 49] and regulating macrophage activation in breast cancer xenograft mouse models [70].